Fangjia Lu, PhD

Dr. Fangjia Lu

ZeaVaxx

Co-Founder / Chief Operation Officer

Dr. Fangjia Lu is the co-founder and Chief Operation Officer of ZeaVaxx LLC. ZeaVaxx is a Purdue University based Ag startup that is working on improving current animal vaccines based on a plant-derived nanoparticle adjuvant platform. Adjuvants are the essential materials included in many vaccine formulations to help achieve the optimal immune response. The company has been one of the winners of Burton D. Morgan Business Plan Competition and was awarded Black Award by Elevate Purdue Fund. ZeaVaxx participated in National Science Foundation I-Corps program in the summer of 2017, in which its business model was further validated through extensive interactions with potential customers and stakeholders in the ecosystem. Dr. Lu graduated from College of Veterinary Medicine at Purdue University, with expertise in vaccines and vaccine adjuvant development. He has published many peer-reviewed articles in journals including Vaccine, Journal of Controlled Release, Journal of Applied Toxicology, npj Vaccines, etc.